{"id":335,"count":4,"description":"<p>Eine randomisierte, multizentrische, Phase-III Studie zum Vergleich von Chemotherapie plus Trastuzumab gegen\u00fcber Chemotherapie plus Trastuzumab plus Bevacizumab als adjuvante Therapie f\u00fcr Patientinnen mit HER2 positivem, Nodal-positivem oder Hochrisiko-Nodal-negativem Brustkrebs.<img title=\"Weiterlesen \u2026\" alt=\"\" src=\"https:\/\/www.abcsg.org\/wp\/wp-includes\/js\/tinymce\/plugins\/wordpress\/img\/trans.gif\" \/><\/p>\r\n<p><strong>Radomisierung geschlossen<\/strong><\/p>\r\n<ul>\r\n<li><a href=\"https:\/\/www.abcsg.org\/?p=5187\"><strong>ABCSG-30 Studieninfos<\/strong><\/a><\/li>\r\n<\/ul>","link":"https:\/\/www.abcsg.org\/en\/tag\/abcsg-30\/","name":"ABCSG 30","slug":"abcsg-30","taxonomy":"post_tag","meta":[],"_links":{"self":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags\/335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/tags"}],"about":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/taxonomies\/post_tag"}],"wp:post_type":[{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/posts?tags=335"},{"href":"https:\/\/www.abcsg.org\/en\/wp-json\/wp\/v2\/pages?tags=335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}